Repotrectinib inhibited proliferation of Ba/F3 cells in vitro, and tumor volumes were decreased in mice expressing Ba/F3 Cd74–Ros1-WT or Cd74-Ros1-G2032R xenograft tumors. Here, CD74 is linked to neoplasm.